Umberger Traci S's Form 4 filing
Kestra Medical Technologies, Ltd. (KMTS) · filed Aug 6, 2026
- Accession no.
- 0001193125-26-338659
- Filed
- Aug 6, 2026, 7:01 PM ET
- Trade date
- Aug 4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $86.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Umberger Traci SCIK 0001877198 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Common Shares | SSaleDisposed | −3,580 | $24.04F2 | −$86,073.22 | 195,825 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.8000 to $24.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Referenced by the price of 1 transaction in Table I.
Remarks
General Counsel and Chief Adminstrative Officer